Alta Embarcadero Biopharma Partners Llc - Net Worth and Insider Trading

Alta Embarcadero Biopharma Partners Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alta Embarcadero Biopharma Partners Llc owns 1 companies in total, including Avadel Pharmaceuticals PLC (AVDL) .

Click here to see the complete history of Alta Embarcadero Biopharma Partners Llc’s form 4 insider trades.

Insider Ownership Summary of Alta Embarcadero Biopharma Partners Llc

Ticker	Comapny	Transaction Date	Type of Owner
AVDL	Avadel Pharmaceuticals PLC	2003-08-27	10 percent owner

Alta Embarcadero Biopharma Partners Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alta Embarcadero Biopharma Partners Llc Ownership Network

Ownership Network List of Alta Embarcadero Biopharma Partners Llc

No Data

Ownership Network Relation of Alta Embarcadero Biopharma Partners Llc

Alta Embarcadero Biopharma Partners Llc Owned Company Details

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Alta Embarcadero Biopharma Partners Llc is the 10 percent owner of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Alta Embarcadero Biopharma Partners Llc made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 41,000 shares were bought by its insiders, resulting in a net sale of 62,975 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

Alta Embarcadero Biopharma Partners Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Alta Embarcadero Biopharma Partners Llc. Currently GuruFocus does not have mailing address information for Alta Embarcadero Biopharma Partners Llc.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.